Price Summary

FinStar

Ownership Stable

Ownership strength is slightly missing the benchmark.

ValuationFair

The stock’s market price justifies its intrinsic value.

EfficiencyPoor

The company seems highly inefficient in case of asset management.

FinancialsVery Stable

The company possesses stable growth history and manageable debt.

Company Essentials

Enterprise Value

710.07 Cr.

Book Value (TTM)

₹  346.34

Your Added Ratios

Please login to Add & View your own added ratios.

Login

 Group Companies

Ratios

Sales Growth

1 Year9.89%

3 Year17.08%

5 Year13.66%

Profit Growth

1 Year10.26%

3 Year23.68%

5 Year31.48%

ROE%

1 Year9.51%

3 Year8.95%

5 Year8.43%

ROCE %

1 Year9.81%

3 Year9.11%

5 Year9.21%

Price to Cash Flow

577.54

Interest Cover Ratio

7.40081805050474

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2021 41.03 15.18
Mar 2021 40.86 41.01
Dec 2020 41.79 40.09
Sep 2020 41.79 36.31
Jun 2020 41.79 44.63

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Net Sales 193.65 23.72 36.03 54.91 215.1
Total Expenditure 149.45 17.86 29.65 43.88 166.57
Operating Profit 44.19 5.85 6.38 11.03 48.53
Other Income 0 0 0.93 0 0
Interest 1.98 2.01 2.1 2.73 2.66
Depreciation 0.67 0.67 0.67 0.81 0.68
Exceptional Items 0 0 0 0 0
Profit Before Tax 41.55 3.17 4.54 7.5 45.2
Tax 0.3 0.15 0.29 0.35 0.29
Profit After Tax 41.26 3.02 4.25 7.14 44.91
Adjusted EPS (Rs) 21.71 1.59 2.24 3.76 23.63

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 169.87 191.65 230.93 279.89 307.56
Total Expenditure 140.87 151.2 187.56 225.1 240.8
Operating Profit 29 40.45 43.37 54.79 66.76
Other Income 0.52 0.94 2.27 1.82 1.67
Interest 9.73 10.39 5.33 6.65 8.87
Depreciation 3.03 0.95 1.45 1.45 2.82
Exceptional Items 0 0 0 0 0
Profit Before Tax 16.75 30.05 38.87 48.51 56.75
Tax 0.47 0.64 0.43 -1.98 1.09
Net Profit 16.28 29.42 38.43 50.48 55.66
Adjusted EPS (Rs.) 10.17 15.48 20.22 26.57 29.29

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 16 19 19 19 19
Total Reserves 287.31 450.23 488.58 538.61 594.27
Borrowings 20.07 0.31 0.5 0.3 0.65
Other N/C liabilities 1.15 1.02 1.16 1.72 2.57
Current liabilities 129.69 99.79 138.68 169.62 173
Total Liabilities 454.23 570.34 647.93 729.25 789.51
Assets
Net Block 207.29 210.94 231.72 246.03 246.93
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 5 5 5 5 5.05
Loans & Advances 0.15 0.18 1.43 5.89 13.64
Other N/C Assets 0 0.02 0.02 0 0
Current Assets 241.79 354.21 409.77 472.33 523.89
Total Assets 454.23 570.34 647.93 729.25 789.51

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 16.75 30.05 38.87 48.51 56.75
Adjustment 12.81 10 4.56 6.99 9.79
Changes in Assets & Liabilities -26.22 -87.16 -63.64 -44.5 -65.13
Tax Paid 0 0.12 -2.72 -1.52 -0.3
Operating Cash Flow 3.34 -46.98 -22.94 9.48 1.11
Investing Cash Flow -4.05 -4.07 -20.48 -14.44 -10.28
Financing Cash Flow 5.33 89.87 20.14 5.56 16.4
Net Cash Flow 4.62 38.81 -23.28 0.61 7.23

Corporate Actions

Super Investors

Investors Details

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Public 47.16 47.17 47.17 48.1 47.92
satpal khattar 2.1 2.1 2.1 2.1 2.1
c mackertich private limi... 0 0 0 0 1.01
authum investment and inf... 0 0 0 0 0
authum investment and inf... 14.08 13.88 0 15.8 15.88
bakulesh trambaklal shah 0 1.39 0 1.42 1.34
authum investment and in... 0 0 14.94 0 0
bakulesh tramnaklal shah 0 0 1.34 0 0
c makertich private limit... 0 0 0 1.01 0
PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
FII/DII 11.04 11.04 11.04 11.05 11.05
indgrowth capital fund i 2.31 2.31 2.31 0 2.31
aditya birla sun life tru... 8.53 8.53 8.53 8.53 8.53

Nath Bio-Genes Stock Price Analysis and Quick Research Report. Is Nath Bio-Genes an attractive stock to invest in?

Stock investing requires careful analysis of financial data to find out the companys true net worth. This is generally done by examining the companys profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a companys performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a companys financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nath Bio-Genes has a PE ratio of 10.7391495183081 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nath Bio-Genes has ROA of 7.3298679643818 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a companys ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nath Bio-Genes has a Current ratio of 3.02821602266394 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nath Bio-Genes has a ROE of 9.50752674488504 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Nath Bio-Genes has a D/E ratio of 0.1575 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a companys inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Nath Bio-Genes has an Inventory turnover ratio of 1.42849693800833 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Nath Bio-Genes has reported revenue growth of 9.88620627227437 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Nath Bio-Genes for the current financial year is 21.7074617123818 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nath Bio-Genes is Rs 2 and the yield is 0.5982 %.

Brief about Nath Bio-Genes

Contact us

Find us at the office

Procter- Lebret street no. 84, 49328 Stanley, Falkland Islands

Give us a ring

Travontae Brummels
+26 237 340 160
Mon - Fri, 7:00-22:00

Contact us